130 related articles for article (PubMed ID: 34514791)
21. Effects of Bailing capsule on diabetic nephropathy based on UPLC-MS urine metabolomics.
Xu J; Yuan Q; Wu K; Li X; Zhao Y; Li X
RSC Adv; 2019 Nov; 9(62):35969-35975. PubMed ID: 35540588
[TBL] [Abstract][Full Text] [Related]
22. Mitochondrial activity contributes to impaired renal metabolic homeostasis and renal pathology in STZ-induced diabetic mice.
Wu M; Li S; Yu X; Chen W; Ma H; Shao C; Zhang Y; Zhang A; Huang S; Jia Z
Am J Physiol Renal Physiol; 2019 Sep; 317(3):F593-F605. PubMed ID: 31268353
[TBL] [Abstract][Full Text] [Related]
23. Integrated metabolomics coupled with pattern recognition and pathway analysis to reveal molecular mechanism of cadmium-induced diabetic nephropathy.
Gong P; Wang M; Yang W; Chang X; Wang L; Chen F
Toxicol Res (Camb); 2021 Aug; 10(4):777-791. PubMed ID: 34484669
[TBL] [Abstract][Full Text] [Related]
24. Tripterygium glycoside tablet attenuates renal function impairment in diabetic nephropathy mice by regulating triglyceride metabolism.
Zhang J; Li SL; Lin W; Pan RH; Dai Y; Xia YF
J Pharm Biomed Anal; 2022 Nov; 221():115028. PubMed ID: 36108463
[TBL] [Abstract][Full Text] [Related]
25. Identification of novel targets of diabetic nephropathy and PEDF peptide treatment using RNA-seq.
Rubin A; Salzberg AC; Imamura Y; Grivitishvilli A; Tombran-Tink J
BMC Genomics; 2016 Nov; 17(1):936. PubMed ID: 27855634
[TBL] [Abstract][Full Text] [Related]
26. Meprin β metalloproteases associated with differential metabolite profiles in the plasma and urine of mice with type 1 diabetes and diabetic nephropathy.
Gooding J; Cao L; Whitaker C; Mwiza JM; Fernander M; Ahmed F; Acuff Z; McRitchie S; Sumner S; Ongeri EM
BMC Nephrol; 2019 Apr; 20(1):141. PubMed ID: 31023251
[TBL] [Abstract][Full Text] [Related]
27. Management of Diabetes Mellitus with Puerarin, a Natural Isoflavone From Pueraria lobata.
Chen X; Yu J; Shi J
Am J Chin Med; 2018; 46(8):1771-1789. PubMed ID: 30525896
[TBL] [Abstract][Full Text] [Related]
28. Non-invasive metabolic biomarkers for early diagnosis of diabetic nephropathy: Meta-analysis of profiling metabolomics studies.
Roointan A; Gheisari Y; Hudkins KL; Gholaminejad A
Nutr Metab Cardiovasc Dis; 2021 Jul; 31(8):2253-2272. PubMed ID: 34059383
[TBL] [Abstract][Full Text] [Related]
29. Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats.
Ge J; Miao JJ; Sun XY; Yu JY
J Ethnopharmacol; 2016 Aug; 189():238-49. PubMed ID: 27224243
[TBL] [Abstract][Full Text] [Related]
30. Identification of isoflavone glycosides in Pueraria lobata cultures by tandem mass spectrometry.
Prasain JK; Reppert A; Jones K; Moore DR; Barnes S; Lila MA
Phytochem Anal; 2007; 18(1):50-9. PubMed ID: 17260698
[TBL] [Abstract][Full Text] [Related]
31. Biomarker discovery in biological specimens (plasma, hair, liver and kidney) of diabetic mice based upon metabolite profiling using ultra-performance liquid chromatography with electrospray ionization time-of-flight mass spectrometry.
Tsutsui H; Maeda T; Min JZ; Inagaki S; Higashi T; Kagawa Y; Toyo'oka T
Clin Chim Acta; 2011 May; 412(11-12):861-72. PubMed ID: 21185819
[TBL] [Abstract][Full Text] [Related]
32. Towards Better Drug Repositioning: Targeted Immunoinflammatory Therapy for Diabetic Nephropathy.
Zhang Q; Yang M; Xiao Y; Han Y; Yang S; Sun L
Curr Med Chem; 2021; 28(5):1003-1024. PubMed ID: 31701843
[TBL] [Abstract][Full Text] [Related]
33. The aldose reductase inhibitor epalrestat exerts nephritic protection on diabetic nephropathy in db/db mice through metabolic modulation.
He J; Gao HX; Yang N; Zhu XD; Sun RB; Xie Y; Zeng CH; Zhang JW; Wang JK; Ding F; Aa JY; Wang GJ
Acta Pharmacol Sin; 2019 Jan; 40(1):86-97. PubMed ID: 29930278
[TBL] [Abstract][Full Text] [Related]
34. Protein tyrosine phosphatase 1B and α-glucosidase inhibitory activities of Pueraria lobata root and its constituents.
Seong SH; Roy A; Jung HA; Jung HJ; Choi JS
J Ethnopharmacol; 2016 Dec; 194():706-716. PubMed ID: 27769948
[TBL] [Abstract][Full Text] [Related]
35. Liraglutide attenuates renal tubular ectopic lipid deposition in rats with diabetic nephropathy by inhibiting lipid synthesis and promoting lipolysis.
Su K; Yi B; Yao BQ; Xia T; Yang YF; Zhang ZH; Chen C
Pharmacol Res; 2020 Jun; 156():104778. PubMed ID: 32247822
[TBL] [Abstract][Full Text] [Related]
36. Metabolomics-based evidence of the hypoglycemic effect of Ge-Gen-Jiao-Tai-Wan in type 2 diabetic rats via UHPLC-QTOF/MS analysis.
Wang W; Zhao L; He Z; Wu N; Li Q; Qiu X; Zhou L; Wang D
J Ethnopharmacol; 2018 Jun; 219():299-318. PubMed ID: 29580854
[TBL] [Abstract][Full Text] [Related]
37. Serum metabolic profiling analysis of gout patients based on UPLC-Q-TOF/MS.
Zhong Z; Huang Y; Huang Q; Zheng S; Huang Z; Deng W; Li T
Clin Chim Acta; 2021 Apr; 515():52-60. PubMed ID: 33388309
[TBL] [Abstract][Full Text] [Related]
38. Urine metabolomics study of Bushen Huoxue Prescription on diabetic retinopathy rats by UPLC-Q-exactive Orbitrap-MS.
Wang X; Li Y; Xie M; Deng L; Zhang M; Xie X
Biomed Chromatogr; 2020 Apr; 34(4):e4792. PubMed ID: 31907953
[TBL] [Abstract][Full Text] [Related]
39. Carnosine alleviates diabetic nephropathy by targeting GNMT, a key enzyme mediating renal inflammation and fibrosis.
Liu XQ; Jiang L; Lei L; Nie ZY; Zhu W; Wang S; Zeng HX; Zhang SQ; Zhang Q; Yard B; Wu YG
Clin Sci (Lond); 2020 Dec; 134(23):3175-3193. PubMed ID: 33241846
[TBL] [Abstract][Full Text] [Related]
40. Metabonomics revealed xanthine oxidase-induced oxidative stress and inflammation in the pathogenesis of diabetic nephropathy.
Liu J; Wang C; Liu F; Lu Y; Cheng J
Anal Bioanal Chem; 2015 Mar; 407(9):2569-79. PubMed ID: 25636229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
